U.S., Feb. 12 -- ClinicalTrials.gov registry received information related to the study (NCT07403669) titled 'Cardiovascular Kidney and Metabolic Health Assessment and Patient Empowerment' on Feb. 04.
Brief Summary: The primary objective of CHAPERONE solution is to evaluate the efficacy of engaging, assessing, and enabling long term treatment strategy with Health AI Chatbot, Copilot, LLM and vital sign monitoring device in reducing CKM disease burden using an algorithm obtained from biomarkers and diagnostics utilizing remote sensor driven technology tools, care coordination and patient empowerment.
Study Start Date: Oct. 22, 2025
Study Type: INTERVENTIONAL
Condition:
Acute MI
Heart Failure
Diabetes Mellitus
Kidney Disease
Intervention...